Clinical trial
Assessment of DHA On Reducing Early Preterm Birth (ADORE Trial)
NCT02626299 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of DHA On Reducing Early Preterm Birth (ADORE Trial)
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 8, 2016
- Completion date
- October 5, 2020
- Enrollment
- 1,100 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
preterm birth